Talis Biomedical Corporation (TLIS)
OTCMKTS · Delayed Price · Currency is USD
1.500
0.00 (0.00%)
Aug 14, 2025, 8:00 PM EDT
Talis Biomedical Company Description
Talis Biomedical Corporation does not have significant operations.
Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States.
The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other strategic transactions.
Talis Biomedical Corporation was incorporated in 2013 and is based in Chicago, Illinois.
Talis Biomedical Corporation
| Country | United States |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 99 |
| CEO | Robert Kelley |
Contact Details
Address: 1375 West Fulton Market Chicago, Delaware 60607 United States | |
| Phone | 650-433-3000 |
| Website | talisbio.com |
Stock Details
| Ticker Symbol | TLIS |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US87424L1089 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Rebecca Markovich | Interim Chief Financial Officer |
| Margaret Barrett M.S. | Controller |
| Gillian Green | Company Secretary |